Take these personality quizzes and share your results with your labmates!

Feel very privileged to be researching #RareDisease at UCL Great Ormond Street Institute of Child Health With over 6000 rare diseases and > 300 M affected worldwide, research is imperative to understanding disease and finding cures. #RareDiseaseDay

So so happy to see this. Celebrating how awesome women are and inspiring girls to be anything they want to be. ‘When you reach for the stars, anything is possible’ Who run the world? GIRLS! #internationalwomensday #STEM. ‘Through science, you can literally change the world’

Successful day in the lab ended by having two abstracts accepted for presentation at the #BNA2023 international festival of neuroscience and publication in the Brain & Neuroscience Advances!See you in Brighton!

Big congrats to Clara Zourray 🌹 for winning this prize! Very well deserved!

Really happy to share this! Novel variant found in DRD1, encoding the Dopamine Receptor 1, involved in infantile Parkinsonism Dystonia. Lovely to work with inspiring and caring scientists and clinicians mdpi.com/2073-4409/12/7…

Such amazing talks, posters and networking at the #BNA2023 #bnafestivalofneuroscience. Feeling inspired, and apparently being inspiring!

Lovely run on Brighton Seafront, resting my neurons before another #BNA2023 style brain workout. strava.app.link/kv7LZBJrhzb

Big congratulations to amy mctague!!

Thank you to all our fundraisers and everyone that has donated and helped make this happen #TogetherWeWillBeatINAD screenshot from LinkedIn bloomsburygtx.com/pipeline/bgt-i…

Paper alert! Excited to share this invited chapter for Elsevier | ScienceDirect international review of neurobiology on targeting neurotransmitter systems in dystonia. Check it out! sciencedirect.com/science/articl…

Bloomsbury Genetic Therapies gets Rare Pediatric Disease designation from the US FDA for the Treatment of Ornithine Transcarbamylase Deficiency (OTCD). AlbionVC UCL Business Ltd Learn more: bit.ly/43x9uGJ

Awesome end to the week getting to share my latest publication, out today in cells. This work on miRNA regulation of Ca2+ homeostasis in mouse ESCs was the focus of my PhD at Royal Veterinary College (RVC) and it feels so great to have it published. Check it out! 👇 mdpi.com/2073-4409/12/1…

We're on a mission to accelerate the pipeline for new treatments, benefiting children with rare diseases and the incredible adults they will grow into. 🧪 Discover the progress we're making at our National Institute for Health and Care Research Biomedical Research Centre with Prof Manju Kurian...

Anyone looking for an RA position, take a look below 👇 amazing project (iPSCs and epilepsy) with an awesome PI in a great place. Check it out!

UCLB spinout Bloomsbury Genetic Therapies recently announced that it has received Orphan Drug Designation from the U.S. FDA for BGT-OTCD for the Treatment of Ornithine Transcarbamylase Deficiency (OTCD). @ucltf UCL Innovation & Enterprise Learn more: bit.ly/3OySMRZ

Bloomsbury Genetic Therapies Ltd we co-founded with Profs ⁦Simon Waddington⁩, Manju Kurian and Paul Gissen shortlisted OBN Awards Best Start-Up Biotech finalists. ⁦UCL School of Pharmacy⁩ ⁦UCL EGA Institute for Women's Health⁩ ⁦@GGM_ICH⁩ ⁦⁦UCL Business Ltd⁩ 🤞🏽👏🏽 linkedin.com/posts/bloomsbu…

We're #hiring a Research Assistant to join a collaborative project developing personalised antisense #oligonucleotidetherapies for paediatric rare #neurodegenerativedisorders with Dr Haiyan Zhou & Manju Kurian UCL Great Ormond Street Institute of Child Health. #RareDisease #NucleicAcidTherapies mrc.tal.net/vx/lang-en-GB/…

If you don’t already know about #RareDisease and #RareDiseaseDay2024 then you really should!! So proud and honoured to be working in this field

Settling in well to my new home Imperial College London in Imperial Life Sciences investigating Human Functional Genomics in #raredisease with a pretty epic run-commute!